Bigbull Pharma (@bigbullpharma4724)
14 days ago
21 Views

Velpanat (Velpatasvir/Sofosbuvir) with its patent of Epclusa finds its applicability in cure of chronic HEP C (hepatitis c) infection. Infection related to HEP C can be treated with VELPANAT.